• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Crimson CatalystEngaging strategic partners. Connecting IU resources. Advancing Indiana’s economy.

Indiana CTSI and IURTC-supported Projects Series: Part 2

Posted on May 22, 2012 by bfravel

As mentioned in the first of the four blogs in this series, the Indiana Clinical and Translational Sciences Institute (Indiana CTSI) set a record last year for supported research projects that have reached the technology transfer phase of their development, including twelve projects that filed invention disclosures with the Indiana University Research and Technology Corp. (IURTC). I am highlighting four of the twelve projects to have entered the commercialization process over the past year. The first blog highlighted Dr. Craig Erickson’s autism research project.

The second project is advancing a new approach to the treatment of bacterial infections by Stan Spinola, M.D., professor and chair of microbiology and immunology, who cited Indiana CTSI funding as a key contributor to early validation of his concept.  His idea, disabling the bacteria’s own stress response system, was recently  protected by IURTC through filing a provisional patent application. The invention’s different mode of action has great commercialization potential because current antibiotics have been exploiting the same basic set of biological pathways over the past 40 years, which has led to bacterial resistance to these drugs. In 2011, Dr. Spinola received more than $21,000 from the Indiana CTSI Clinical Project Development Team to support this research as well as services from the Indiana CTSI Clinical Research Center, Bioethics and Subject Advocacy Program, and Design and Biostatics Program. 

This is the second of four blogs. Check back soon for the next posting in the series on Indiana CTSI/IURTC-supported projects.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: UncategorizedTagged CTSI, education, faculty research, Health Care, Higher Education, Higher Education & Innovation, Higher Education and Innovation, Indiana University, IU Research & Technology Corporation, IU Research and Technology Corporation, IU School of Medicine, IURTC, Research, Technology Commercialization, Technology Transfer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Crimson Catalyst

Subscribe to the Crimson Catalyst Blog

Sign up to receive regular updates from Crimson Catalyst Blog

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

About Crimson Catalyst

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond.

Crimson Catalyst is maintained by the Indiana University Office of the Vice President for Engagement.

About the Authors

Bill Stephan
Tony Armstrong
David Gard
Kirk White
Joe Carley
Rebecca Carl
Steve Martin
Subscribe to Innovate Indiana’s Insights newsletter
Innovate Twitter Button
Innovate LinkedIn Button

Archives by Year

2018
2017
2016
2015
2014
2013
2012
2011
2010

Categories

  • Alumni
  • Defense Partnerships
  • Economic Development
  • Engagement
  • Entrepreneurship
  • Faculty
  • International Engagement
  • IU Innovation and Commercialization Office
  • IU Regional Campuses
  • IU Research & Technology Corporation
  • IU Ventures
  • Research
  • Staff
  • Statewide Engagement
  • Students
  • Technology Commercialization
  • Uncategorized
  • Workforce Development

Celebrating 200 years

Indiana University

Copyright © 2018 The Trustees of Indiana University | Privacy Notice | Accessibility Help